Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Takeda
University of Washington
National Institutes of Health Clinical Center (CC)
Georgetown University
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Pfizer
Pfizer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ethicon, Inc.
City of Hope Medical Center
Imunon
Big Ten Cancer Research Consortium
BTG International Inc.
Cellxpert Biotechnology Corp.
University of California, San Diego
New Mexico Cancer Research Alliance
Sirtex Medical
Indiana University
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
Alliance for Clinical Trials in Oncology
Emory University
Merck KGaA, Darmstadt, Germany
University of Alabama at Birmingham
Roswell Park Cancer Institute
Massachusetts General Hospital
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Stanford University
Emory University
University of Utah
New Mexico Cancer Research Alliance
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute